ASIT biotech Continues Its Transformation From Research to Late Stage Clinical Development

01:04 EDT 1 Jul 2019 | FinanzNachrichten

Company shareholders approve all motions at Extraordinary General Meeting Firm expects to raise €9-12 M to finance focused development Jean-Paul Prieels confirmed as new member of Board of Directo...

More From BioPortfolio on "ASIT biotech Continues Its Transformation From Research to Late Stage Clinical Development"